<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03576300</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00006761-M2017354</org_study_id>
    <nct_id>NCT03576300</nct_id>
  </id_info>
  <brief_title>Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome</brief_title>
  <official_title>Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to compare the differences of ocular surface features in controls and patients
      with diabetes and dry eye syndrome, to thoroughly evaluate the ocular surface health of
      diabetics, and to find out the relationship between dry eye syndrome and diabetes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we perform a completely comparison of ocular surface characteristic including
      the Ocular Surface Disease Index (OSDI) questionnaire,tearfilm break up time(BUT),corneal
      fluorescein scores(CFS),Shirmer test,corneal sensitivity)among diabetic patients with DE,
      diabetic patients without DE, non-diabetic patients with DE and normal subjects and analysis
      of EGF, IL-17A, IL-1β, IL-8 and TNF-α in tears and their clinical correlations are also
      performed to investigate potential biomarkers for diagnosis of diabetic with DE.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tear cytokines levels</measure>
    <time_frame>through study completion,an average of two weeks</time_frame>
    <description>Comparision the tear cytokines （EGF, IL-17A, IL-1β, IL-8 and TNF-α）levels in different groups using using a Milliplex Map Kit (Human Th17 Magnetic Bead Panel, Millipore, Billerica, MA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical correlations of the tear cytokines</measure>
    <time_frame>through study completion,an average of two weeks</time_frame>
    <description>Analysis of tear cytokines and clinical correlations by Spearman correlation coefficient</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>subjects without dry eye and diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with diabetes and dry eye</arm_group_label>
    <description>diabetic patients with dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetics without dry eye syndrome</arm_group_label>
    <description>diabetic patients without dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dry eye syndrome patients without diabetes</arm_group_label>
    <description>non-diabetic patients with dry eye</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      tears from the subjects
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Asian
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. dry eye diagnosis according to Expert's Consensus About Clinical Diagnosis and
             Treatment（Corneal Disease Group of Ophthalmological Society, Chinese Medical
             Association）: ①OSDI≥13，②positive dry eye soigns(ST≤10mm/5min；BUT≤10s；CFS＞0)

          2. type 2 diabetes diagnosis according to American Diabetes Association：Standards of
             Medical Care in Diabetes -2017(ADA, American Diabetes Association)

          3. Willing to sign the consent form.

        Exclusion Criteria:

          1. Having known Eye infection, allergy, malformation, abnormal eye movement

          2. Exclusion of eye injury, any kind of eye surgery

          3. Exclusion of other disease may cause neuropathy or influence tear producing

          4. Using systematic or local antibiotics that may influence tear producing

        Elimianation Criteria

          1. poor compliance

          2. voluntary withdrawal

          3. any other kind of situation that researchers consider not suitable for further study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Qi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rongjun Liu, MD</last_name>
    <phone>18801229560</phone>
    <email>383223952@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Qi, MD</last_name>
      <email>doctorqihong@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 3, 2018</study_first_posted>
  <last_update_submitted>June 21, 2018</last_update_submitted>
  <last_update_submitted_qc>June 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Third Hospital</investigator_affiliation>
    <investigator_full_name>Hong Qi</investigator_full_name>
    <investigator_title>MD.PHD.</investigator_title>
  </responsible_party>
  <keyword>ocular surface</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

